Mesoblast Return on Equity (ROE) Growth & History (MESO)

Mesoblast's return on equity was −9.86% for fiscal 2026.

View full Mesoblast company overview

Mesoblast annual return on equity history

Mesoblast annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20262026-06-30−9.86%+9.09 pp
20252025-06-30−18.95%−1.04 pp
20242024-06-30−17.91%−1.51 pp
20232023-06-30−16.40%+0.54 pp
20222022-06-30−16.94%+0.54 pp
20212021-06-30−17.48%−2.35 pp
20202020-06-30−15.13%+2.36 pp
20192019-06-30−17.49%−10.85 pp
20182018-06-30−6.64%+8.06 pp
20172017-06-30−14.70%

Mesoblast return on equity trends

Over the last five fiscal years, Mesoblast's return on equity increased from −17.48% to −9.86%, a change of +7.61 percentage points. The latest reported quarter, Q3 2023, shows −3.70%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Mesoblast source filings ↗

Community posts

It’s quiet here.

No posts about MESO yet. Start the conversation.

Write the first post